Genomic Classifier in Prostate Cancer: Intermediate-Risk

The Future of Prostate Cancer Risk Stratification and Treatment Planning - Eric Kim

May 10, 2024

Details

The Future of Prostate Cancer Diagnosis: Combining Non-Invasive Tests for Personalized Care - Eric Kim

May 10, 2024

Details

Investigating the Relationship Between MRI Findings, Genomic Markers, and Gleason Score - Eric Kim

May 10, 2024

Details

Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen

April 3, 2024

Details

Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions - Paul Nguyen

December 5, 2023

Details

Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt

November 7, 2023

Details

A Comprehensive Look at Genomic Classifier Performance in Intermediate Risk Prostate Cancer: Insights from the NRG Oncology/RTOG 01-26 Trial, Journal Club - Rashid Sayyid & Zachary Klaassen

August 22, 2023

Details

Risk Assessment in Localized Prostate Cancer - Insights from Real-World Data and SEER Registry - Jim Hu

May 9, 2023

Details

Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi

January 30, 2023

Details

Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER® Genomic Classifier for Prostate Cancer - Ashley Ross

January 24, 2023

Details

The Use of Genomics in Unfavorable Intermediate-risk Prostate Cancer - David Morris

December 20, 2022

Details

PORTOS as a Predictive Biomarker to Help Personalize Radiotherapy Dose in the Postoperative Setting, in the SAKK 09/10 Trial - Alan Dal Pra

December 5, 2022

Details

An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abiraterone Acetate and Prednisolone - Gerhardt Attard

October 3, 2022

Details

Rationale for the Use of Decipher® RP Genomic Classifier to Inform Treatment - Ashley Ross

July 31, 2022

Details

The Use of the Decipher® Biopsy Test Prior to Prostatectomy - Ashley Ross

July 31, 2022

Details

Treatment of Unfavorable Intermediate Risk Prostate Cancer - Ashley Ross, Jason Hafron, and Katie Murray

June 14, 2022

Details

Validation of Performance of the Decipher® Biopsy Genomic Classifier in Intermediate-Risk Prostate Cancer: The Phase III Randomized Trial NRG Oncology/RTOG 0126 – Jeff Michalski

February 24, 2022

Details

When to Add ADT to Early or Late Salvage Radiation - Dan Spratt

August 18, 2021

Details

Validation of a Prognostic Genomic Classifier in Salvage Radiotherapy Prostate Cancer from a Prospective Randomized Trial - Felix Feng

February 22, 2020

Details

Data from the RTOG 9601 Study: Treating Prostate Cancer Patients with Low-Volume Disease - Daniel Spratt

December 31, 2019

Details